Scientific news

Arizona school says cannabis could treat cancer pain instead of opioids

Cannabis could soon take the place of opioids in treating pain caused by breast cancer, the University of Arizona said.

CBD may protect against psychiatric risk from high-THC cannabis strains

Neuroscientists have found that cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC...

Cannabics pharmaceuticals files a patent application for sensitivity tests of cannabinoids

Cannabics Pharmaceuticals announced today that it has filed an extensive provisional patent application with the US Patent & Trademark Office on a new method for sensitivity tests of cannabinoids on patient-derived tumor biopsies and CTCs.

Study: THCA may help protect the brain

Researchers in Spain have reported that the cannabinoid tetrahydrocannabinolic acid (THCA) could be useful in treating degenerative diseases of the brain.

Endocannabinoid system involved in obesity-induced nephropathy

A study in mice pinpointed exactly where and how the endocannabinoid system mediates obesity-induced nephropathy, suggesting a new approach for treating the condition, researchers reported.

Cannabis may be more effective at reducing anxiety than traditional medication, new study finds

Chronic marijuana users were found to have a “blunted” response to stress.

Deep Cell Industries receives cannabinoid infusion patent

Deep Cell Industries announces notice of allowance for crystal fusion patent by U.S. patent office.

Cannabis shows promise in treating Schizophrenia and Tourette Syndrome

Early research suggests that patients with some of the hardest-to-treat mental health disorders could find significant relief from cannabis.

Medical marijuana studied as replacement for opioids

A Nanaimo-based researcher believes cannabis could help reduce opioid overdoses and help people overcome addiction.

Altasciences clinical research offers innovative cannabis research solutions

Altasciences is pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug.